Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome

Renee G. Beer, Maureen Rischmueller, Toby Coates, Anthony W. Purcell, Catherine L. Keech, James McCluskey, Tom P. Gordon

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)

Abstract

Anti-La(SS-B) precipitin-negative sera show a restricted epitope recognition and can be easily overlooked in routine laboratory testing. We have therefore determined the prevalence of nonprecipitating anti-La(SS-B) antibodies in patients with primary Sjogren's syndrome and studied their clinical and immunological associations. Clinical details were obtained from 68 patients with primary Sjogren's syndrome, and serum samples were examined by enzyme-linked immunosorbent assay using purified recombinant La, 60-kDa Ro, and 52-kDa Ro proteins and by counterimmunoelectrophoresis. Thirteen patients (19%) were identified with anti-La antibodies which were nonprecipitating. These patients had similar clinical findings to other groups of patients with Sjogren's syndrome, but had significantly lower rheumatoid factor and serum IgG levels than patients with anti-La precipitins. None of the patients with nonprecipitating anti-La antibodies had previously contained anti-La precipitins in their sera. Furthermore, they tended to have lower levels of antibodies directed against denatured 60-kDa Ro (but not 52-kDa Ro) compared with anti-La precipitin-positive patients. Patients with Sjogren's syndrome associated with nonprecipitating anti-La antibodies represent a stable serological and clinical subset in which there appears to be limited diversification of the autoimmune response to the Ro60 and La proteins of the Ro/La ribonucleoprotein.

Original languageEnglish
Pages (from-to)314-318
Number of pages5
JournalClinical Immunology and Immunopathology
Volume79
Issue number3
DOIs
Publication statusPublished - 1 Jan 1996
Externally publishedYes

Cite this

Beer, R. G., Rischmueller, M., Coates, T., Purcell, A. W., Keech, C. L., McCluskey, J., & Gordon, T. P. (1996). Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome. Clinical Immunology and Immunopathology, 79(3), 314-318. https://doi.org/10.1006/clin.1996.0084
Beer, Renee G. ; Rischmueller, Maureen ; Coates, Toby ; Purcell, Anthony W. ; Keech, Catherine L. ; McCluskey, James ; Gordon, Tom P. / Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome. In: Clinical Immunology and Immunopathology. 1996 ; Vol. 79, No. 3. pp. 314-318.
@article{0bef72f3e4f94cec80f284e5a6e3a3da,
title = "Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome",
abstract = "Anti-La(SS-B) precipitin-negative sera show a restricted epitope recognition and can be easily overlooked in routine laboratory testing. We have therefore determined the prevalence of nonprecipitating anti-La(SS-B) antibodies in patients with primary Sjogren's syndrome and studied their clinical and immunological associations. Clinical details were obtained from 68 patients with primary Sjogren's syndrome, and serum samples were examined by enzyme-linked immunosorbent assay using purified recombinant La, 60-kDa Ro, and 52-kDa Ro proteins and by counterimmunoelectrophoresis. Thirteen patients (19{\%}) were identified with anti-La antibodies which were nonprecipitating. These patients had similar clinical findings to other groups of patients with Sjogren's syndrome, but had significantly lower rheumatoid factor and serum IgG levels than patients with anti-La precipitins. None of the patients with nonprecipitating anti-La antibodies had previously contained anti-La precipitins in their sera. Furthermore, they tended to have lower levels of antibodies directed against denatured 60-kDa Ro (but not 52-kDa Ro) compared with anti-La precipitin-positive patients. Patients with Sjogren's syndrome associated with nonprecipitating anti-La antibodies represent a stable serological and clinical subset in which there appears to be limited diversification of the autoimmune response to the Ro60 and La proteins of the Ro/La ribonucleoprotein.",
author = "Beer, {Renee G.} and Maureen Rischmueller and Toby Coates and Purcell, {Anthony W.} and Keech, {Catherine L.} and James McCluskey and Gordon, {Tom P.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1006/clin.1996.0084",
language = "English",
volume = "79",
pages = "314--318",
journal = "Clinical Immunology and Immunopathology",
issn = "0090-1229",
number = "3",

}

Beer, RG, Rischmueller, M, Coates, T, Purcell, AW, Keech, CL, McCluskey, J & Gordon, TP 1996, 'Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome', Clinical Immunology and Immunopathology, vol. 79, no. 3, pp. 314-318. https://doi.org/10.1006/clin.1996.0084

Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome. / Beer, Renee G.; Rischmueller, Maureen; Coates, Toby; Purcell, Anthony W.; Keech, Catherine L.; McCluskey, James; Gordon, Tom P.

In: Clinical Immunology and Immunopathology, Vol. 79, No. 3, 01.01.1996, p. 314-318.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome

AU - Beer, Renee G.

AU - Rischmueller, Maureen

AU - Coates, Toby

AU - Purcell, Anthony W.

AU - Keech, Catherine L.

AU - McCluskey, James

AU - Gordon, Tom P.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Anti-La(SS-B) precipitin-negative sera show a restricted epitope recognition and can be easily overlooked in routine laboratory testing. We have therefore determined the prevalence of nonprecipitating anti-La(SS-B) antibodies in patients with primary Sjogren's syndrome and studied their clinical and immunological associations. Clinical details were obtained from 68 patients with primary Sjogren's syndrome, and serum samples were examined by enzyme-linked immunosorbent assay using purified recombinant La, 60-kDa Ro, and 52-kDa Ro proteins and by counterimmunoelectrophoresis. Thirteen patients (19%) were identified with anti-La antibodies which were nonprecipitating. These patients had similar clinical findings to other groups of patients with Sjogren's syndrome, but had significantly lower rheumatoid factor and serum IgG levels than patients with anti-La precipitins. None of the patients with nonprecipitating anti-La antibodies had previously contained anti-La precipitins in their sera. Furthermore, they tended to have lower levels of antibodies directed against denatured 60-kDa Ro (but not 52-kDa Ro) compared with anti-La precipitin-positive patients. Patients with Sjogren's syndrome associated with nonprecipitating anti-La antibodies represent a stable serological and clinical subset in which there appears to be limited diversification of the autoimmune response to the Ro60 and La proteins of the Ro/La ribonucleoprotein.

AB - Anti-La(SS-B) precipitin-negative sera show a restricted epitope recognition and can be easily overlooked in routine laboratory testing. We have therefore determined the prevalence of nonprecipitating anti-La(SS-B) antibodies in patients with primary Sjogren's syndrome and studied their clinical and immunological associations. Clinical details were obtained from 68 patients with primary Sjogren's syndrome, and serum samples were examined by enzyme-linked immunosorbent assay using purified recombinant La, 60-kDa Ro, and 52-kDa Ro proteins and by counterimmunoelectrophoresis. Thirteen patients (19%) were identified with anti-La antibodies which were nonprecipitating. These patients had similar clinical findings to other groups of patients with Sjogren's syndrome, but had significantly lower rheumatoid factor and serum IgG levels than patients with anti-La precipitins. None of the patients with nonprecipitating anti-La antibodies had previously contained anti-La precipitins in their sera. Furthermore, they tended to have lower levels of antibodies directed against denatured 60-kDa Ro (but not 52-kDa Ro) compared with anti-La precipitin-positive patients. Patients with Sjogren's syndrome associated with nonprecipitating anti-La antibodies represent a stable serological and clinical subset in which there appears to be limited diversification of the autoimmune response to the Ro60 and La proteins of the Ro/La ribonucleoprotein.

UR - http://www.scopus.com/inward/record.url?scp=0029894218&partnerID=8YFLogxK

U2 - 10.1006/clin.1996.0084

DO - 10.1006/clin.1996.0084

M3 - Article

VL - 79

SP - 314

EP - 318

JO - Clinical Immunology and Immunopathology

JF - Clinical Immunology and Immunopathology

SN - 0090-1229

IS - 3

ER -